Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Accro Bioscience inks over $50M series B round 2022-01-05 11:08
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec 2022-01-05 10:00
BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics 2022-01-05 08:07
CAI Announces CEO Succession 2022-01-04 22:33
Origin Agritech Announces Collaboration with BaoDao Feed Ltd. To Commercialize Nutrition Enhanced Corn 2022-01-04 22:10
Molecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of Directors 2022-01-04 19:00
Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003 2022-01-04 17:28
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002 2022-01-04 10:00
TCI's Golden Formula Has Won the Best Plant-Based Functional Product in the World Plant-Based Awards 2021 2022-01-04 09:00
Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer 2022-01-04 08:00
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD 2022-01-03 18:00
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm 2022-01-03 14:24
CStone Pharmaceuticals announced the IND approval of CS5001, a potential global best-in-class ROR1-targeting ADC by the U.S. Food and Drug Administration 2022-01-03 08:00
GBB Closed the A Round Financing with Newly Joined FutureX Capital 2021-12-31 20:44
Landmark international innovation and entrepreneurship competition concludes in China's Chongqing with top prize worth 100 mln yuan 2021-12-31 19:15
GenFleet Therapeutics Raises $75 Million in Series C Financing Led by Huagai Capital, to Advance Innovative Pipeline Highlighting Cutting-edge Therapies 2021-12-31 19:00
China Medical System (867.HK)'s Latest MSCI ESG Rating Unchanged at AA, Leading the Industry Globally 2021-12-30 20:00
Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology 2021-12-30 19:18
Antengene Announces First Patient Dosed in REACH Study of ATG-016 for the Treatment of Advanced Solid Tumors 2021-12-30 09:51
Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane 2021-12-29 19:00
1 188 189 190 191 192 440